Literature DB >> 16985837

Detecting Prostate Cancer with Molecular Markers: uPM3.

Stephen J Freedland, Alan W Partin.   

Abstract

Entities:  

Year:  2005        PMID： 16985837      PMCID： PMC1477583     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  7 in total

1.  Prostate cancers in men with low PSA levels--must we find them?

Authors:  H Ballentine Carter
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

2.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

3.  DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Authors:  M J Bussemakers; A van Bokhoven; G W Verhaegh; F P Smit; H F Karthaus; J A Schalken; F M Debruyne; N Ru; W B Isaacs
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

4.  DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer.

Authors:  Martina Tinzl; Michael Marberger; Sabine Horvath; Camille Chypre
Journal:  Eur Urol       Date:  2004-08       Impact factor: 20.096

5.  DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Authors:  Daphne Hessels; Jacqueline M T Klein Gunnewiek; Inge van Oort; Herbert F M Karthaus; Geert J L van Leenders; Bianca van Balken; Lambertus A Kiemeney; J Alfred Witjes; Jack A Schalken
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

6.  uPM3, a new molecular urine test for the detection of prostate cancer.

Authors:  Yves Fradet; Fred Saad; Armen Aprikian; Jean Dessureault; Mostafa Elhilali; Claude Trudel; Benoît Mâsse; Lyson Piché; Camille Chypre
Journal:  Urology       Date:  2004-08       Impact factor: 2.649

7.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors:  Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245
  7 in total
  2 in total

Review 1.  Diagnostic value of urine prostate cancer antigen 3 test using a cutoff value of 35 μg/L in patients with prostate cancer.

Authors:  Bin Hu; Hongmei Yang; Hongwei Yang
Journal:  Tumour Biol       Date:  2014-05-27

2.  Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.

Authors:  Wei He; Sumith A Kularatne; Kimberly R Kalli; Franklyn G Prendergast; Robert J Amato; George G Klee; Lynn C Hartmann; Philip S Low
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.